DigestRedComo funciona
Red
/
Empresas
Ta
No verificado

Takeda Pharmaceutical Company Limited

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

56 Comunicados de prensa

Ver todos los comunicados de prensa
05/08/2026
Industria
Salud
Higiene alimentaria
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
30/07/2026
Web y redes sociales
Telefonía
Mercado de valores
Acciones y Obligaciones
Eventos
Oncología
Salud
Higiene alimentaria
Farmacéutica
Biotecnología
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
16/07/2026
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
12/07/2026
Mercado laboral
Industria
Medicina - Varios
Material médico sanitario
Sanidad
Gestión empresarial
Biotecnología
Salud
Farmacéutica
Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
24/06/2026
Mercado laboral
Biotecnología
Farmacéutica
Salud
Oncología
Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
15/06/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
11/06/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Medicina - Varios
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
09/06/2026
Industria
Salud
Higiene alimentaria
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
13/05/2026
Web y redes sociales
Telefonía
Mercado de valores
Acciones y Obligaciones
Biotecnología
Farmacéutica
Salud
Oncología
Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
04/05/2026
Industria
Salud
Ciencia
Farmacéutica
Medicina - Varios
Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0